NO20014697L - Anvendelse av vasopeptidaseinhibitorer for å behandle angina pectoris - Google Patents

Anvendelse av vasopeptidaseinhibitorer for å behandle angina pectoris

Info

Publication number
NO20014697L
NO20014697L NO20014697A NO20014697A NO20014697L NO 20014697 L NO20014697 L NO 20014697L NO 20014697 A NO20014697 A NO 20014697A NO 20014697 A NO20014697 A NO 20014697A NO 20014697 L NO20014697 L NO 20014697L
Authority
NO
Norway
Prior art keywords
angina pectoris
vasopeptidase inhibitors
treat angina
treat
vasopeptidase
Prior art date
Application number
NO20014697A
Other languages
English (en)
Norwegian (no)
Other versions
NO20014697D0 (no
Inventor
James R Powell
Henry H Holzgrefe
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO20014697L publication Critical patent/NO20014697L/no
Publication of NO20014697D0 publication Critical patent/NO20014697D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20014697A 1999-03-29 2001-09-27 Anvendelse av vasopeptidaseinhibitorer for å behandle angina pectoris NO20014697D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12694299P 1999-03-29 1999-03-29
PCT/US2000/006091 WO2000057883A1 (en) 1999-03-29 2000-03-09 Use of vasopeptidase inhibitors to treat angina pectoris

Publications (2)

Publication Number Publication Date
NO20014697L true NO20014697L (no) 2001-09-27
NO20014697D0 NO20014697D0 (no) 2001-09-27

Family

ID=22427490

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014697A NO20014697D0 (no) 1999-03-29 2001-09-27 Anvendelse av vasopeptidaseinhibitorer for å behandle angina pectoris

Country Status (17)

Country Link
US (1) US6140319A (pt)
EP (1) EP1165088A4 (pt)
JP (1) JP2002540157A (pt)
KR (1) KR20020002487A (pt)
CN (1) CN1347321A (pt)
AU (1) AU768880B2 (pt)
BR (1) BR0009289A (pt)
CA (1) CA2368616A1 (pt)
CZ (1) CZ20013453A3 (pt)
HK (1) HK1039894A1 (pt)
HU (1) HUP0200662A3 (pt)
IL (1) IL144285A0 (pt)
MX (1) MXPA01009654A (pt)
NO (1) NO20014697D0 (pt)
RU (1) RU2245147C2 (pt)
WO (1) WO2000057883A1 (pt)
ZA (1) ZA200107962B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040198839A1 (en) * 2000-08-23 2004-10-07 Dean Herbert M. Cardioprotective dosage units
US20030035839A1 (en) * 2001-05-15 2003-02-20 Peirce Management, Llc Pharmaceutical composition for both intraoral and oral administration
US20030144269A1 (en) * 2001-12-20 2003-07-31 Block Alan J. Reducing pulse pressures and vascular stiffness in hypertensive patients by administering a vasopeptidase inhibitor
WO2008001311A2 (en) * 2006-06-26 2008-01-03 Ranbaxy Laboratories Limited Pharmaceutical composition containing fixed dose combination of atenolol with isosorbide mononitrate
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR880007441A (ko) * 1986-12-11 1988-08-27 알렌 제이.스피겔 스피로-치환된 글루타르아미드 이뇨제
WO1992000276A2 (en) * 1990-06-22 1992-01-09 Fisons Plc Angiotensis converting enzyme inhibitors
GB9103454D0 (en) * 1991-02-19 1991-04-03 Pfizer Ltd Therapeutic agents
US5294632A (en) * 1991-05-01 1994-03-15 Ciba-Geigy Corporation Phosphono/biaryl substituted dipetide derivatives
US5155100A (en) * 1991-05-01 1992-10-13 Ciba-Geigy Corporation Phosphono/biaryl substituted dipeptide derivatives
US5250522A (en) * 1992-10-09 1993-10-05 Ciba-Geigy Corporation Phosphono/biaryl substituted amino acid derivatives
US5244889A (en) * 1991-11-26 1993-09-14 Ciba-Geigy Corporation Certain macrocyclic lactam derivatives
US5217996A (en) * 1992-01-22 1993-06-08 Ciba-Geigy Corporation Biaryl substituted 4-amino-butyric acid amides
US5552397A (en) * 1992-05-18 1996-09-03 E. R. Squibb & Sons, Inc. Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase
ES2111689T3 (es) * 1992-11-17 1998-03-16 Smith & Nephew Inc Dispositivo de bloqueo para la inmovilizacion de un hilo de sutura.
GB9310075D0 (en) * 1993-05-17 1993-06-30 Fujisawa Pharmaceutical Co New mercapto-amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
US5508272A (en) * 1993-06-15 1996-04-16 Bristol-Myers Squibb Company Compounds containing a fused bicycle ring and processes therefor
AU7186094A (en) * 1993-06-30 1995-01-24 Ciba-Geigy Ag Antihypertensive tricyclic azepine derivatives useful as inhibitors of enkephalinase and ace
DE69424846T2 (de) * 1993-11-16 2000-11-16 Novartis Ag Zyklische Aminosäure-Derivate mit ACE und NEP inhibierender Aktivität
JPH09509150A (ja) * 1994-01-28 1997-09-16 シーエーエル・インターナショナル・リミテッド エステル化可能なａｃｅ阻害剤のサリチレートを含む医薬製造物
US5508266A (en) * 1994-06-22 1996-04-16 Ciba-Geigy Corporation Gem-disubstituted amino acid derivatives
FR2729668A1 (fr) * 1995-01-23 1996-07-26 Adir Nouveaux derives de mercaptoalcanoyldipeptides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US5744781A (en) * 1995-08-07 1998-04-28 General Electric Company Method and apparatus for laser shock peening
CA2332608C (en) * 1998-06-17 2010-03-23 Bristol-Myers Squibb Company Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination

Also Published As

Publication number Publication date
IL144285A0 (en) 2002-05-23
CN1347321A (zh) 2002-05-01
HUP0200662A2 (hu) 2002-07-29
MXPA01009654A (es) 2002-05-14
WO2000057883A1 (en) 2000-10-05
HK1039894A1 (zh) 2002-05-17
KR20020002487A (ko) 2002-01-09
EP1165088A1 (en) 2002-01-02
RU2245147C2 (ru) 2005-01-27
JP2002540157A (ja) 2002-11-26
EP1165088A4 (en) 2002-09-04
BR0009289A (pt) 2002-01-22
HUP0200662A3 (en) 2004-07-28
ZA200107962B (en) 2003-01-02
AU3732100A (en) 2000-10-16
NO20014697D0 (no) 2001-09-27
AU768880B2 (en) 2004-01-08
CA2368616A1 (en) 2000-10-05
US6140319A (en) 2000-10-31
CZ20013453A3 (cs) 2002-02-13

Similar Documents

Publication Publication Date Title
EE05430B1 (et) Imidasolo-5-l-2-anilino-primidiinid raku proliferatsiooni inhibitsiooni agensitena
EE200300015A (et) Kolhinooli derivaadid kui angiogeneesi inhibiitorid
ATE376999T1 (de) Hydroxamate-derivate als deacetylase inhibitoren
IL148698A0 (en) INHIBITORS OF FACTOR Xa
DE60020100D1 (de) Dimerverbindungen und als inhibitoren der neuramidinase
NO20031658D0 (no) EP4 reseptorinhibitorer for å behandle reumatoid artritt
NO20014535L (no) Inhibitorer av IMPDH-enzym
NO20015112L (no) Anvendelse av glykosylceramidsynteseinhibitorer ved terapi
NO20015206D0 (no) Renin inhibitorer
AU2001236605A1 (en) Indole and benzimidazole inhibitors of factor xa
NO20022125D0 (no) Pyrrolderivater som inhibitorer for fosfodiesterase VII
NO20020742D0 (no) Innskrenkning av innretninger for å lyddempe operasjoner
EE200100039A (et) Ftalasiinderivaadid kui fosfodiesteraas-4 inhibiitorid
EE200100371A (et) Amidinobensüülamiini derivaadid ja nende kasutamine trombiini inhibiitoritena
NO20021658L (no) Asfaltenhemmere
AU2003259445A8 (en) Copy protection of dvd related web content
NO20020279D0 (no) Anvendelse av alkylenaminer for å fremme kalkslamavvanning
NO20014697L (no) Anvendelse av vasopeptidaseinhibitorer for å behandle angina pectoris
PT1165136E (pt) Terapia de combinacao de inibidores da enzima de conversao da antagonista da aldosterona epoxi-esteroidal para tratamento de doenca cardiovascular
NO20005301D0 (no) Pyrrolidiner som inhibitorer av neuraminidaser
NO20020153L (no) Bruk av interleukin-18 inhibitorer for å hemme tumormetastase
WO2001074348A8 (en) Vasopeptidase inhibitors to treat isolated systolic hypertension
NO20013832D0 (no) Piperidin- og piperazinderivater som hemmere ved Abeta-fibril- dannelsen
NO20023354D0 (no) Anvendelse av FSH til å behandle infertilitet
DE60009260D1 (de) Thiopyranderivate as mmp-inhibitoren

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application